5. Time lost due to liver cancer diagnosis and treatment.

Variables	Patients (N=2,139) (d)	Caregivers* (N=2,139) (d)	Overall number of days lost
			Value (d)	Statistics**	P**
*, Patients’ relatives and friends; **, Two-sample Student test after logarithm transition for two groups comparative analysis; analysis of variance (ANOVA) test after logarithm transition for more than two groups comparison; CNY, Chinese Yuan.
Total	41.7	31.4	73.1	−	−
Hospital type
General	40.5	27.9	68.4	−4.21	<0.001
Specialized	42.1	32.5	74.7
Age at diagnosis (year)
<45	45.2	28.6	73.8	3.45	0.016
45−54	45.9	34.4	80.3
55−64	38.0	31.3	69.3
≥65	39.3	29.6	68.9
Sex
Male	42.4	31.8	74.2	0.94	0.346
Female	38.9	29.9	68.8
Education
Primary school or below	38.2	30.9	69.1	2.95	0.031
Junior high school	42.8	29.9	72.7
Senior high school	41.7	33.4	75.1
Undergraduate or over	49.0	32.8	81.8
Occupation
Farmer	40.0	31.0	70.9	1.17	0.320
Enterprise or company employee/worker	40.8	32.1	72.8
Self-employed or unemployee	42.1	27.1	69.2
Retiree	45.8	31.8	77.6
Staff in institution/civil servant	48.9	38.8	87.7
Other	37.1	29.3	66.4
Health-care insurance type
Urban employees’ basic medical insurance	47.4	33.4	80.9	5.93	<0.001
Urban residents’ basic medical insurance	37.8	32.5	70.3
New rural cooperative medical scheme	39.0	29.5	68.5
Commercial insurance	24.5	15.0	39.5
Self-financed	24.4	21.7	46.1
Other	46.3	37.6	84.0
Previous year household income (CNY)
<20,000	37.2	32.7	69.9	4.70	0.003
20,000−39,999	43.1	32.0	75.1
40,000−69,999	45.9	32.2	78.1
≥70,000	39.3	30.0	69.3
Clinical stage
I	39.2	27.1	66.3	2.60	0.050
II	44.7	34.0	78.7
III	42.6	30.0	72.6
IV	39.5	35.2	74.7
Therapeutic regimen
Surgery	42.6	25.5	68.1	4.05	<0.001
Chemotherapy	41.2	35.4	76.6
Surgery and postoperative chemotherapy	38.7	28.4	67.1
Symptomatic treatment	43.8	32.3	76.1
Concurrent chemoradiotherapy	36.6	47.2	83.8
Radiotherapy	53.5	42.0	95.5
Neoadjuvant chemoradiotherapy and surgery	63.8	31.7	95.5
Pathological type
Hepatocellular carcinoma	41.4	29.1	70.5	1.17	0.243
Other	41.1	27.9	69.0